Profiling of ecstasy tablets seized in iran

Area of Science:

• Forensic Chemistry
• Analytical Chemistry
• Pharmacology

Background:

• Ecstasy (MDMA) is a widely used recreational drug.
• Illicit drug analysis is crucial for public health and law enforcement.
• Understanding the composition of seized drugs aids in identifying trends and risks.

Purpose of the Study:

• To characterize the physical and chemical properties of ecstasy tablets seized in Iran between 2007 and 2008.
• To identify the active ingredients and quantify the 3,4-methylenedioxymethamphetamine (MDMA) content.
• To investigate potential adulterants and variations in tablet composition.

Main Methods:

• Physical examination including appearance, marking, color, weight, diameter, and thickness.
• Chemical analysis using color tests (Marquis, Simon's, Chen's, Gallic acid).
• Chromatographic techniques (TLC, GC-MS, LC-MS) for identification and quantification of active compounds and residual solvents.

Main Results:

• 50 ecstasy tablets were analyzed; 80% contained 3,4-methylenedioxymethamphetamine (MDMA) hydrochloride, ranging from 60-180 mg.
• Tablet weights varied (96-308 mg) with no strong correlation to MDMA content.
• Adulterants such as ketamine, phenmetrazine, ephedrine, caffeine, and tramadol were detected in some tablets; 20% lacked MDMA.

Conclusions:

• Significant variability exists in the composition of seized ecstasy tablets.
• MDMA content does not reliably correlate with tablet weight.
• The presence of adulterants highlights potential risks and the need for ongoing drug monitoring.